Scientists test high doses of antiviral drug in healthy people
NCT ID NCT06024421
Summary
This early-stage study aims to test the safety of giving high doses of the antiviral drug favipiravir to healthy volunteers for 14 days. Researchers will closely monitor participants for side effects and measure how the drug moves through and is processed by the body, including its levels in blood and sperm. The goal is to gather essential safety and processing data to inform future research, not to treat an active infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Bichat - Claude Bernard
RECRUITINGParis, 75018, France
Contact
Contact
Conditions
Explore the condition pages connected to this study.